Cyclooxygenase products contribute to endothelin-induced pulmonary hypertension and altered lung mechanics in sheep

Pulmonary Pharmacology and Therapeutics

Volumn 10, Issue 2, 1997, Pages 111-118

  Snapper, James R ^a,b   Lu, Weixuan ^a   Lefferts, Peter L ^a   Thabes, John S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY HOSPITAL   (United States)

Author keywords

Bronchoconstriction; Cyclooxygenase; Endothelin; Pulmonary hypertension; Vasoconstriction

Indexed keywords

ARACHIDONIC ACID; CLOTIAZEPAM; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; FEMALE; INTRAARTERIAL DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG COMPLIANCE; LUNG FLUID; LUNG LYMPH FLOW; LUNG MECHANICS; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SHEEP;

EID: 0031545197     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1997.0085     Document Type: Article

References (36)

1. 1. Yanagisawa M, Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci 1989; 10: 374-378.
2. 2. Hay D W, Henry P J, Goldie R G. Endothelin and the respiratory system. Trends Pharmacol Sci 1993; 14: 29-32.
3. 3. Sokolovsky M. Endothelins and sarafotoxins: physiological regulation, receptor subtypes and transmembrane signaling. Pharmacol Ther 1992; 54: 129-149.
4. 4. Sibbald W J, Paterson N A, Holliday R L, Anderson R A, Lobb T R, Duff J H. Pulmonary hypertension in sepsis: measurement by the pulmonary arterial diastolic-pulmonary wedge pressure gradient and the influence of passive and active factors. Chest 1978; 73: 583-591.
5. 5. Watkins W D, Huttemeier P C, Kong D, Peterson M B. Thromboxane and pulmonary hypertension following E. coli endotoxin infusion in sheep: effect of an imidazole derivative. Prostaglandins 1982; 23: 273-285.
6. 6. Staub N C, Bland R D, Brigham K L, Demling R, Erdmann A J, Woolverton W C. Preparation of chronic lung lymph fistulas in sheep. J Surg Res 1975; 19: 315-320.
7. 7. Snapper J R, Hutchison A A, Ogletree M L, Brigham K L. Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep. J Clin Invest 1983; 72: 63-76.
8. 8. von Neergaard K, Wirz K. Über eine Methode zur Messung der Lungenelastizität am lebenden Menschen, inbesondere beim Emphysem. Z Klin Med 1927; 105: 35-50.
9. 9. Newman J H, Loyd J E, Ogletree M L, Meyrick B O, Brigham K L. Cyclooxygenase inhibition during phorbol-induced granulocyte stimulation in awake sheep. J Appl Physiol 1984; 56: 999-1007.
10. 10. Ogletree M L, Begley C J, King G A, Brigham K L. Influence of steroidal and nonsteroidal anti-inflammatory agents on the accumulation of arachidonic acid metabolites in plasma and lung lymph after endotoxemia in awake sheep. Measurements of prostacyclin and thromboxane metabolites and 12-HETE. Am Rev Respir Dis 1986; 133: 55-61.
11. 4 on the lungs of unanesthetized sheep. Respiration 1987; 51: 256-265.
12. 12. Trochtenberg D S, Lefferts P L, King G A, Hwang Y S, Christman B W, Snapper J R. Effects of thromboxane synthase and cyclooxygenase inhibition on PAF-induced changes in lung function and arachidonic acid metabolism. Prostaglandins 1992; 44: 555-557.
13. 13. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
14. 14. Boichot E, Lagente V, Mencia-Huerta J M, Braquet P. Bronchopulmonary responses to endothelin-1 in sensitized and challenged guinea-pigs: role of cyclooxygenase metabolites and platelet-activating factor. Fundam Clin Pharmacol 1993; 7: 281-291.
15. 15. el-Mowafy A M, Abou-Mohamed G A. Endothelins-induce cyclicAMP formation in the guinea-pig trachea through an ETA receptor-and cyclooxygenase-dependent mechanism. Br J Pharmacol 1996; 118: 531-536.
16. 16. Lippton H L, Hauth T A, Summer W R, Hyman A L. Endothelin produces pulmonary vasoconstriction and systemic vasodilation. J Appl Physiol 1989; 66: 1008-1012.
17. 17. Lippton H L, Ohlstein E H, Summer W R, Hyman A L. Analysis of responses to endothelins in the rabbit pulmonary and systemic vascular beds. J Appl Physiol 1991; 70: 331-341.
18. 18. Matsuda H, Beppu S, Ohmori F, Yamada M, Miyatake K. Involvement of cyclo-oxygenase-generated vasodilating eicosanoid(s) in addition to nitric oxide in endothelin-1-induced endothelium-dependent vasorelaxation in guinea pig aorta. Heart Vessels 1993; 8: 121-127.
19. 19. Nally J E, McCall R, Young L C, Wakelam M J, Thomson N C, McGrath J C. Mechanical and biochemical responses to endothelin-1 and endothelin-3 in human bronchi. European J Pharmacol 1994; 288: 53-60.
20. 20. Toga H, Usha Rah J, Hillyard R, Ku B, Anderson J. Endothelin effects in isolated, perfused lamb lungs: role of cyclooxygenase inhibition and vasomotor tone. Am J Physiol 1991; 261: H443-H450.
21. 21. Abraham W M, Ahmed A, Cortes A, Spinella M J, Malik A B, Andersen T T. A specific endothelin-1 antagonist blocks inhaled endothelin-1-induced bronchoconstriction in sheep. J Appl Physiol 1993; 74: 2537-2542.
22. 2 release in mediating of endothelin-1 induced bronchoconstriction and vasopressin in the guinea-pig. Prostaglandins Leukot Essent Fatty Acids 1993; 48: 261-263.
23. 23. Pons F, Loquet I, Touvay C, Roubert P, Chabrier P E, Mencia-Huerta J M, Braquet P. Comparison of the bronchopulmonary and pressor activities of endothelin isoforms ET-1, ET-2, and ET-3 and characterization of their binding sites in guinea pig lung. Am Rev Respir Dis 1991; 143: 294-300.
24. 24. De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner T D, Vane J R. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 9797-9800.
25. 25. Horgan M J, Pinheiro M B, Malik A B. Mechanism of endothelin-1-induced pulmonary vasoconstriction. Circulation Research 1991; 69: 157-164.
26. 26. Mann J, Farrukh I S, Michael J R. Mechanisms by which endothelin 1 induces pulmonary vasoconstriction in the rabbit. J Appl Physiol 1991; 71: 410-416.
27. 27. Rae G A, Trybulec M, De Nucci G, Vane J R. Endothelin-1 releases eicosanoids from rabbit isolated perfused kidney and spleen. J Cardiovasc Pharmacol 1989; 13: S89-S92.
28. 28. Thiemermann C, Lidbury P S, Thomas G R, Vane J R. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit. J Cardiovasc Pharmacol 1989; 13: S138-S141.
29. 29. Warner T D, Mitchell J A, De Nucci G, Vane J R. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol 1989; 13: S85-S88.
30. 30. Miller V M, Komori K, Burnett Jr J C, Vanhoutte P M. Differential sensitivity to endothelin in canine arteries and veins. Am J Physiol 1989; 257: H1127-H1131.
31. 2 receptor in the vasoconstrictor response of rat aorta to endothelin. J Pharmacol Exp Ther 1990; 252: 915-921.
32. 32. Le Monnier de Gouville A C, Mondot S, Lippton H, Hyman A, Cavero I. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats. J Pharmacol Exp Ther 1990; 252: 300-311.
33. 33. Sugiura M, Inagami T, Kon V Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989; 161: 1220-1227.
34. 34. Whittle B J R, Lopez-Belmonte J, Rees D D. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol 1989; 98: 646-652.
35. 35. Esbenshade A M, Newman J H, Lams P M, Jolles H, Brigham K L. Respiratory failure after endotoxin infusion in sheep: lung mechanics and lung fluid balance. J Appl Physiol 1982; 53: 967-976.
36. 36. Payne A N, Whittle B J R. Potent cyclo-oxygenase-mediated bronchoconstrictor effects of endothelin in the guinea-pig in vivo. Eur J Pharmacol 1988; 158: 303-304.